2cureX - Individualizing Cancer Treatment
2cureX is about improving cancer treatment with the individual patient in focus
By testing the patient’s cancer cells for their sensitivity against approved anti-cancer drugs, IndiTreat® helps the oncologist in selecting the most effective treatment for the individual cancer patient.
IndiTreat® does not predict; but measures the treatment effectiveness and resistance for the individual cancer patient. The right individual cancer treatment saves the patient from unnecessary side effects and provides cost efficiency in drug-spending.
To establish IndiTreat® as the global standard for measuring an individual cancer patient’s response to different drug therapy options.
To make a real difference for individual cancer patients around the world by matching the most optimal therapy with the individual treatment needs.
News and Press Releases
Press releases regulatory
Press releasesPress releases regulatory